Dr. Hallman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Philadelphia, PA 19111Phone+1 215-728-6900Fax+1 215-214-4038
Education & Training
- Temple University Hospital/Fox Chase Cancer CenterResidency, Radiation Oncology, 2010 - 2014
- Medical University of South Carolina College of MedicineInternship, Transitional Year, 2009 - 2010
- Medical University of South CarolinaClass of 2009
- University of the SciencesB.S., Pharmacology and Toxicology, Magna Cum Laude, 1994 - 1998
Certifications & Licensure
- PA State Medical License 2010 - 2024
- SC State Medical License 2009 - 2010
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha Medical Honor Society 2009
Publications & Presentations
PubMed
- 25 citationsTen-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate CancerV. Avkshtol, Karen Ruth, Eric A. Ross, Mark A. Hallman, Richard E. Greenberg
Journal of Clinical Oncology. 2020-03-02 - 18 citationsPatient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancerSkyler B. Johnson, Pamela R. Soulos, Timothy D. Shafman, Constantine A. Mantz, Amy M. Dosoretz
Radiotherapy and Oncology. 2016-11-01 - 19 citationsA Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasi...Noah M Hahn, Michael A O'Donnell, Jason A Efstathiou, Marianna Zahurak, Gary L Rosner
European Urology. 2023-06-01
Journal Articles
- Radiation therapy to the primary tumor in locally advanced prostate cancer is not "closing the barn door after the horse has bolted"Zaorsky N, Smaldone MC, Annals of Translational Medicine, 1/1/2015
- Effect of antioxidants on para-aminophenol-induced toxicity in LLC-PK1 cellsTcaho R, Tarloff JB, Toxicology, 1/1/2000
Books/Book Chapters
Abstracts/Posters
- Impact of Regional Nodal Irradiation on Outcomes of Breast Cancer Patients with 1-3 Positive Axillary NodesKeller L, Anderson P, Tam T, ASTRO National Meeting, Boston, MA, 1/1/2012
- A Model of Redifferentiation in Primary Cultures of Regenerating Renal Proximal Tubule CellsHallman MA and Schnellmann RG, NIDDK – Kidney Development Injury and Repair Conference, Alexandria, VA, 1/1/2007
- Epidermal Growth Factor Receptor Regulates Dedifferentiation/Redifferentiation in Regenerating Renal Proximal Tubular CellsHallman MA and Schnellmann RG, Society of Toxicology – National Meeting, Charlotte, NC, 1/1/2007
- Join now to see all
Lectures
- Lung Stereotactic Body Radiation Therapy: Past, Present and FutureFox Chase Cancer Center, Philadelphia, PA - 1/10/2015
- Strategies in Lung Stereotactic Body Radiation TherapyFox Chase Cancer Center, Philadelphia, PA - 1/18/2014
- The Impact of Dose Heterogeneity on Local Recurrence (LR) Rates Following Stereotactic Body Radiotherapy (SBRT)San Francisco, CA - 1/1/2014
- Join now to see all
Grant Support
- EGF Receptor As A Therapeutic Target In Renal FailureNational Institute Of Environmental Health Sciences2004–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: